Posterior Cornea in Primary Open Angle Glaucoma

NCT ID: NCT02356094

Last Updated: 2015-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-31

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Characterization of posterior corneal changes in primary open angle glaucoma patients, using Scheimpflug examination.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A cohort of primary open angle glaucoma (POAG) patients is submitted to Scheimpflug Pentacam examination. The results are compared with a control group of age and central corneal thickness matched healthy subjects

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cases

Patients with primary open angle glaucoma, randomly selected from the Glaucoma Outpatient Clinic to be submitted to Pentacam examination

Pentacam

Intervention Type PROCEDURE

Corneal topography using Scheimpflug Pentacam examination

Controls

Control group of age and central corneal thickness matched healthy subjects, randomly selected from the General Ophthalmology Outpatient Clinic to be submitted to Pentacam examination

Pentacam

Intervention Type PROCEDURE

Corneal topography using Scheimpflug Pentacam examination

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pentacam

Corneal topography using Scheimpflug Pentacam examination

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary open angle glaucoma, with the diagnosis supported on structural and functional complementary exams according to the current European Glaucoma Society guidelines
* Healthy subjects from the General Ophthalmology Outpatient Clinic

Exclusion Criteria

* age inferior to 18 years old
* primary closed angle glaucoma
* secondary open angle glaucoma
* previous intra-ocular surgery
* known or suspected corneal disease
* previous intra-ocular inflammation
* previous ocular trauma
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centro Hospitalar do Baixo Vouga

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pedro Gil

Pedro Gil, MSc, MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pedro Gil, MSc, MD

Role: PRINCIPAL_INVESTIGATOR

Centro Hospitalar Baixo Vouga

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centro Hospitalar Baixo Vouga

Aveiro, Aveiro District, Portugal

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pedro Gil, MSc, MD

Role: CONTACT

00351915687941

João Gil, MSc, MD

Role: CONTACT

00351915821918

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pedro Gil, MSc, MD

Role: primary

00351234378300

Rita Matos, MSc, MD

Role: backup

00351914452190

References

Explore related publications, articles, or registry entries linked to this study.

Arranz-Marquez E, Bolivar G, Pinero DP, Konstas AG, Mikropoulos DG, Teus MA. Orbscan topography in primary open-angle glaucoma. Optom Vis Sci. 2013 Oct;90(10):1098-103. doi: 10.1097/OPX.0000000000000019.

Reference Type RESULT
PMID: 23939294 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHBaixoVouga2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Glaucoma Portugal Screening Trial
NCT05875090 ENROLLING_BY_INVITATION NA
Advanced Glaucoma Progression Study
NCT01742819 ACTIVE_NOT_RECRUITING